Evelyn Arambula

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Prefrontal Cortex

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Ling He, Angeliki Ioannidis, Carter J Hoffman, Evelyn Arambula, Purva Joshi, Julian P Whitelegge, Linda M Liau, Harley I Kornblum, Frank Pajonk
Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1. Cancer research communications 4 (6) (2024)
Ling He, Angeliki Ioannidis, Carter J Hoffman, Evelyn Arambula, Purva Joshi, Julian P Whitelegge, Linda M Liau, Harley I Kornblum, Frank Pajonk
Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1. Cancer research communications 4 (6) (2024)
Ling He, Angeliki Ioannidis, Carter J Hoffman, Evelyn Arambula, Purva Joshi, Julian P Whitelegge, Linda M Liau, Harley I Kornblum, Frank Pajonk
Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1. Cancer research communications (2024)
Ling He, Angeliki Ioannidis, Carter J Hoffman, Evelyn Arambula, Purva Joshi, Julian P Whitelegge, Linda M Liau, Harley I Kornblum, Frank Pajonk
Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1. Cancer research communications 4 (6) (2024)
Ling He, Angeliki Ioannidis, Carter J Hoffman, Evelyn Arambula, Purva Joshi, Julian P Whitelegge, Linda M Liau, Harley I Kornblum, Frank Pajonk
Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1. Cancer research communications (2024)
Ling He, Angeliki Ioannidis, Carter J Hoffman, Evelyn Arambula, Purva Joshi, Julian P Whitelegge, Linda M Liau, Harley I Kornblum, Frank Pajonk
Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1. Cancer research communications 4 (6) (2024)